CollPlant Biotechnologies (CLGN) Change in Cash (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Change in Cash came in at -$3.0 million in Q4 2025, up 14.62% YoY from -$2.6 million in Q4 2024, and down 2.39% on a QoQ basis from -$2.9 million in Q3 2025.
CollPlant Biotechnologies (CLGN) Change in Cash (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 8 years of Change in Cash data on file, last reported at -$3.0 million in Q4 2025.
- Quarterly Change in Cash rose 14.62% year-over-year to -$3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.6 million (up 41.71% YoY) and the FY2025 annual result came in at -$6.3 million, up 57.21% from the prior year.
- Change in Cash fell to -$3.0 million in Q4 2025, from -$2.9 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $28.1 million in Q1 2022 to a low of -$12.6 million in Q4 2021.
- A 5-year average of $1.3 million and a median of -$2.9 million in 2025 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 794.62% in 2021, down 2396.83% in 2021.
- Tracing CLGN's Change in Cash over 5 years: stood at -$12.6 million in 2021, then surged by 235.6% to $17.1 million in 2022, then slumped by 114.73% to -$2.5 million in 2023, then tumbled by 37.49% to -$3.5 million in 2024, then rose by 14.62% to -$3.0 million in 2025.
- The last three Change in Cash figures came in at -$3.0 million (Q4 2025), -$2.9 million (Q3 2025), and $699000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.96 Mn |
| Sep 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | 699,000.00 |
| Dec 31, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.55 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Mar 31, 2024 | -3.45 Mn |
| Dec 31, 2023 | -2.52 Mn |
| Sep 30, 2023 | 6.62 Mn |
| Jun 30, 2023 | -4.21 Mn |
| Mar 31, 2023 | -3.07 Mn |
| Dec 31, 2022 | 17.10 Mn |
| Sep 30, 2022 | -2.78 Mn |
| Jun 30, 2022 | -5.02 Mn |
| Mar 31, 2022 | 28.15 Mn |
| Dec 31, 2021 | -12.61 Mn |
| Sep 30, 2021 | 8.31 Mn |
| Jun 30, 2021 | -2.30 Mn |
| Mar 31, 2021 | 16.45 Mn |
| Dec 31, 2020 | -505,000.00 |